Endogenous Epoxygenases Are Modulators of Monocyte/Macrophage Activity
Open Access
- 19 October 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10) , e26591
Abstract
Arachidonic acid is metabolized through three major metabolic pathways, the cyclooxygenase, lipoxygenase and CYP450 enzyme systems. Unlike cyclooxygenase and lipoxygenases, the role of CYP450 epoxygenases in monocyte/macrophage-mediated responses is not known. When transfected in vitro, CYP2J2 is an efficient activator of anti-inflammatory pathways through the nuclear receptor peroxisome proliferator-activated receptor (PPAR) α. Human monocytes and macrophages contain PPARα and here we show they express the epoxygenases CYP2J2 and CYP2C8. Inhibition of constitutive monocyte epoxygenases using the epoxygenase inhibitor SKF525A induces cyclooxygenase (COX)-2 expression and activity, and the release of TNFα, and can be reversed by either add back of the endogenous epoxygenase products and PPARα ligand 11,12- epoxyeicosatrienoic acid (EET) or the addition of the selective synthetic PPARα ligand GW7647. In alternatively activated (IL-4-treated) monocytes, in contrast to classically activated cells, epoxygenase inhibition decreased TNFα release. Epoxygenases can be pro-inflammatory via superoxide anion production. The suppression of TNFα by SKF525A in the presence of IL-4 was associated with a reduction in superoxide anion generation and reproduced by the superoxide dismutase MnCl2. Similar to these acute activation studies, in monocyte derived macrophages, epoxygenase inhibition elevates M1 macrophage TNFα mRNA and further decreases M2 macrophage TNFα. In conclusion, epoxygenase activity represents an important endogenous pathway which limits monocyte activation. Moreover endogenous epoxygenases are immuno-modulators regulating monocyte/macrophage activation depending on the underlying activation state.Keywords
This publication has 40 references indexed in Scilit:
- Reduced endothelial dependent vasodilation in vessels from TLR4−/− mice is associated with increased superoxide generationBiochemical and Biophysical Research Communications, 2011
- Cytochrome P450 2J2 Is Highly Expressed in Hematologic Malignant Diseases and Promotes Tumor Cell GrowthThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in miceThe FASEB Journal, 2010
- Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension‐induced renal injury in miceThe FASEB Journal, 2010
- Epoxyeicosatrienoic acids and endothelium-dependent responsesPflügers Archiv - European Journal of Physiology, 2010
- The Epoxygenases CYP2J2 Activates the Nuclear Receptor PPARα In Vitro and In VivoPLOS ONE, 2009
- CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) studyPharmacogenetics and Genomics, 2007
- PPARα Deficiency in Inflammatory Cells Suppresses Tumor GrowthPLOS ONE, 2007
- Macrophage Polarization Comes of AgeImmunity, 2005
- Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aortaBritish Journal of Pharmacology, 1999